Invitae Corporation (NYSE: NVTA) today announced that members of the company’s management team will present at the 2015 Morgan Stanley Global Healthcare Conference on Friday, September 18, 2015 at approximately 8:45 a.m. Eastern / 5:45 a.m. Pacific in New York City.
The live, listen-only webcast of the presentation may be accessed by visiting the Investors section of the company’s website at ir.invitae.com. A replay of the webcasts will be available shortly after the conclusion of the presentation and will be archived on the company’s website.
Invitae’s (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time and lower price than many single-gene tests today. The company currently provides a single diagnostic service comprising more than 200 genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, hematology, and other disease areas.
Source: Invitae Corporation